Differentially Abundant Bacterial Taxa Associated with Prognostic Variables of Crohn’s Disease: Results from the IMPACT Study
Authors:
- Soo-Kyung ParkSPSoo-Kyung Park
- Han-Na KimHan-Na Kim
- Chang Hwan ChoiCCChang Hwan Choi
- Jong Pil ImJIJong Pil Im
- Jae Myung ChaJCJae Myung Cha
- Chang Soo EunCEChang Soo Eun
- Tae-Oh KimTKTae-Oh Kim
- Sang-Bum KangSKSang-Bum Kang
- Ki Bae BangKBKi Bae Bang
- Hyun Gun KimHKHyun Gun Kim
- Yunho JungYJYunho Jung
- Hyuk YoonHYHyuk Yoon
Open Access
- 5 June 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1748
Abstract
Limited studies have examined the intestinal microbiota composition in relation to Crohn’s disease (CD) prognosis. We analyzed the differences in microbial communities and relevant metabolic pathways associated with prognostic variables in patients with CD. We applied 16S rRNA gene sequencing to analyze a cohort of 1110 CD and healthy control (HC) fecal samples. We categorized patients with CD into good (CD-G), intermediate (CD-I) and poor (CD-P) prognosis groups, according to the history of using biologics and intestinal resection. Microbiota α-diversity decreased more in CD-P than CD-G and CD-I. Microbiota ß-diversity in CD-P differed from that in CD-G and CD-I. Thirteen genera and 10 species showed differential abundance between CD-G and CD-P groups. Escherichia coli (p = 0.001) and species Producta (p = 0.01) and genera Lactobacillus (p = 0.003) and Coprococcus (p = 0.01) consistently showed differences between CD-G and CD-P groups after adjusting for confounding variables. Functional profiling suggested that the microbial catabolic pathways and pathways related to enterobacterial common antigen and lipopolysaccharide biosynthesis were better represented in the CD-P group than in the CD-G group, and E. coli were the top contributors to these pathways. CD prognosis is associated with altered microbiota composition and decreased diversity, and E. coli might be causally involved in CD progression, and may have adapted to live in inflammatory environments.Keywords
Funding Information
- National Research Foundation (NRF) Grant funded by the Korea government (NRF-2017R1A2B2009596)
This publication has 40 references indexed in Scilit:
- Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentGenome Biology, 2012
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease PhenotypesGastroenterology, 2010
- UniFrac: an effective distance metric for microbial community comparisonThe ISME Journal, 2010
- Metabolic Shifts in Immunity and InflammationThe Journal of Immunology, 2010
- The role of Escherichia coli in inflammatory bowel diseaseGut, 2007
- Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel DiseaseJournal of Clinical Microbiology, 2005
- Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's diseaseInternational Journal of Medical Microbiology, 2002
- Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel DiseaseInfection and Immunity, 2000
- Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel DiseaseEmerging Infectious Diseases, 2000